Remove Cannabinoids Remove Clinical Trials Remove Food
article thumbnail

CBD Topical Medicine: What Does the Science Say?

Project CBD

Consider it a testament to the ubiquity and flexibility of the endocannabinoid system: we can inhale medicinal cannabinoids via combustion or vaporization; ingest them via food or drink; and absorb them directly through the skin, the bodys largest organ. New clinical trials are urgently needed, they repeat in a familiar refrain.

Topical 176
article thumbnail

Cannabinoids and Inflammation: The Complete Guide

Miss Marijuana

If you want to learn how cannabinoids—special parts of the cannabis plant—might help, you’re in the right place. In this guide, we’ll talk about what cannabinoids are, how they work, and what the latest research says about them and inflammation. If you’re not sure, talk to a doctor who knows about cannabinoids. Want more tips?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medical Cannabis and Anxiety: Natural Treatment Options

Miss Marijuana

Cannabis, with its cannabinoids, can tap into this system, helping to create a more relaxed, balanced state. Clinical trials have been looking into both THC and CBD and their individual roles in treating anxiety. When choosing a product, look at the cannabinoid profile to see which one aligns with your needs!

article thumbnail

5 foods that can affect your high

The Cannigma

But along with music and movies, there are also specific foods that can affect your high, and we don’t just mean in terms of the munchies. Certain foods naturally contain chemicals that may be able to affect your high — either by amplifying or tempering it — and can also interact with your body’s endocannabinoid system.

Food 145
article thumbnail

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

(“IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.

article thumbnail

Oxford Cannabinoid Technologies Holdings plc: Post IPO Review & Notice of Pre-Close Trading Update

Cannabis Law Report

On 1 June 2021, the Group announced an agreement with Voisin Consulting SARL (“VC”), a life sciences consultancy comprising over 200 professionals in the UK, US and India, with expertise in medical devices, cannabinoids, neurological disorders and addictions.

article thumbnail

UK: Assoc For The Cannabinoid Industry Founder Says UK World’s Biggest Market After The US

Cannabis Law Report

Britain’s Food Standards Agency now regulates the sector and its marketing, after the European Union classified CBD as food in 2019. Such products will generate sales of £690 million ($856 million, 811 million euros) in 2021, according to the Association for the Cannabinoid Industry (ACI).